Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pregnancy after lung transplantation: TRIGGER study on antihuman leukocyte antigen alloimmunization and antibody-mediated rejection risk.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025

Same author

Donor to recipient age matching in lung transplantation: A European experience.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024

Same author

[Lung transplantation for cystic fibrosis and bronchiectasis].

Revue des maladies respiratoires·2023

Same author

[Updated indications and contraindications in 2022 for lung transplantation in France].

Revue des maladies respiratoires·2022

Same author

[Spontaneous pneumomediastinum].

Revue des maladies respiratoires·2022

Same author

Impact of the Covid-19 pandemic and lung transplantation program in France.

Respiratory medicine and research·2020

Search research articles

Related Experiment Video

Updated: Aug 8, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

[Chronic lung allograft dysfunction in 2022, past and updates].

P Halitim¹, A Tissot²

¹Service de pneumologie et soins intensifs, Hôpital européen Georges-Pompidou, Assistance publique-Hôpitaux de Paris, 75015 Paris, France; Service de pneumologie, CHU de Nantes, l'Institut du thorax, Nantes Université, Inserm, Center for Research in Transplantation and Translational Immunology, UMR 1064, 44093 Nantes cedex, France.

Revue Des Maladies Respiratoires

|March 1, 2023

Summary

This summary is machine-generated.

Long-term lung transplant survival is limited by chronic lung allograft dysfunction (CLAD), a condition causing fibrosis. Current research focuses on anti-fibrotic therapies and biomarkers to combat this major challenge.

Keywords:

Biomarkers Biomarqueurs Chronic lung lesion Graft rejection Lung transplantation Lésion chronique du poumon Rejet de greffe Transplantation pulmonaire

More Related Videos

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Related Experiment Videos

Last Updated: Aug 8, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Area of Science:

Immunology
Transplantation Medicine
Pulmonary Medicine

Context:

Lung transplantation outcomes lag behind other solid organs.
Chronic Lung Allograft Dysfunction (CLAD) affects nearly 50% of recipients within 5 years.
CLAD is the primary cause of late mortality post-lung transplant.

Purpose:

To review the current understanding of CLAD pathophysiology.
To highlight the limitations of existing treatments for CLAD.
To discuss emerging therapeutic strategies and biomarkers for CLAD.

Summary:

CLAD involves immune and non-immune factors triggering fibrotic processes in lung allografts.
Identified CLAD phenotypes include airway obstruction and interstitial lung disease.
No current treatments can reverse established CLAD, necessitating novel approaches.

Impact:

Improved understanding of CLAD mechanisms is crucial for developing effective therapies.
Targeting fibrotic pathways and utilizing biomarkers may offer new treatment avenues.
Advancing CLAD research is essential to improve long-term lung transplant survival.